Practical implications of in vitro stability of cardiac markers.
Woltersdorf
W W
WW
Department of Chemical Pathology, Bristol Royal Infirmary, UK. wolfram.woltersdorf@ubht.swest.nhs.uk
Bayly
G R
GR
Day
A P
AP
D001219:Aspartate Aminotransferases / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D001798:Blood Proteins / Q000032:analysis*; D009202:Cardiomyopathies / Q000097:blood / Q000175:diagnosis*; D003402:Creatine Kinase / Q000097:blood*; D052279:Creatine Kinase, MB Form; D004795:Enzyme Stability / Q000502:physiology; D006801:Humans; D007527:Isoenzymes / Q000097:blood*; D008403:Mass Screening / Q000592:standards*; D019210:Troponin I / Q000097:blood; D020107:Troponin T / Q000097:blood
D015415:Biomarkers; D001798:Blood Proteins; D007527:Isoenzymes; D019210:Troponin I; D020107:Troponin T; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase; D052279:Creatine Kinase, MB Form